---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-204098"
form_type: "8-K"
ticker: "NDSN"
cik: "0000072331"
company_name: "NORDSON CORP"
filed_at: "2024-08-21T23:59:59+00:00"
generated_at: "2026-05-31T08:21:18.971509+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nordson completes acquisition of Atrion for $460 per share; borrows $825M

## Summary
- Completed acquisition of Atrion Corp. on Aug 21, 2024; stockholders received $460.00 per share in cash.
- Borrowed $500M under a 364-day term loan and $325M under revolving credit facility to fund the merger.
- Atrion specializes in medical infusion fluid delivery and cardiovascular solutions, expanding Nordson's medical portfolio.
- Atrion survives as a wholly owned subsidiary of Nordson after the merger.

## SEC filing metadata
- accession: 0001193125-24-204098
- form_type: 8-K
- ticker: NDSN
- cik: 0000072331
- company_name: NORDSON CORP
- filed_at: 2024-08-21T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.03, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72331/000119312524204098/0001193125-24-204098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72331/000119312524204098/d874837d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-204098
- JSON: https://secwatch.observer/filing/0001193125-24-204098.json
- Plain text: https://secwatch.observer/filing/0001193125-24-204098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.